Conversely, lower SLC44A2 expression was associated with better survival in pancreatic adenocarcinoma (PAAD), invasive breast cancer (BRCA), and adrenocortical carcinoma (ACC). The gene discussed is SLC44A2; the disease is invasive breast carcinoma.